Term-life insurance provides pure death-benefit protection for a fixed period (e.g. 10, 20 or 30 years) in exchange for level premiums. You choose term length (number of years or target age) and coverage amount (lump-sum death benefit ). If you die during the term, your insurer pays the full benefit, tax-free, to your named beneficiary.
Through VKB (Our insurance partner)
Choose any term-life provider in your country. Designate Tomorrow Biostasis GmbH as beneficiary. This guarantees the death benefit flows straight to your cryonics plan, no matter which insurer you select.
Whole-life insurance provides lifelong coverage with fixed premiums. Part of each payment funds a cash-value account that grows tax-deferred.
A Discretionary Trust for cryopreservation is a specialized legal structure that serves dual purposes: covering all costs associated with your cryopreservation contract and providing financial resources for the trust owner if they are successfully revived in the future. The trust receives initial funding, uses portion of these funds to pay for cryopreservation services, then invests and grows the remaining capital over the storage period. If revival becomes possible, the accumulated funds ensure the revived person has financial resources to restart their life in whatever future time period they find themselves in, covering living expenses, adaptation costs, and other needs while trustees maintain discretionary power to allocate funds between ongoing storage costs and building this revival fund based on changing circumstances. The discretionary trust offers UK residents the most flexible and tax-efficient way to ensure your cryopreservation is properly funded, even decades into the future. Unlike direct arrangements, discretionary trusts adapt to changing circumstances, technologies, and legal requirements over the extended timeframes that cryopreservation requires.
Pre-payment is a direct funding method where individuals can pay Tomorrow.bio directly for cryopreservation services, bypassing traditional insurance or trust arrangements. We accept pre-payment when a patient has a confirmed medical prognosis with life expectancy of less than 12 months. Direct payment when a patient is in critical condition or has recently passed away and immediate arrangements are required. These funding options provide certainty for cryopreservation services during time-sensitive situations when traditional long-term funding methods may not be practical or sufficient to secure the necessary services.
Alternative funding methods encompass any payment arrangements that don't fit our standard categories but can provide immediate liquidity prior to cryopreservation procedures. These are evaluated on a case-by-case basis, requiring a consultation call to assess the feasibility and structure of the proposed funding approach. If you select this option, our team will schedule a discussion to explore your specific circumstances and determine whether your proposed method meets our operational requirements.
Disclaimer: Last Will arrangements are not accepted as Alternative Funding Methods due to significant tax implications, potential family disputes, and operational risks. Tomorrow.bio must advance €120,000 to the Patient Care Trust immediately upon cryopreservation, but Last Will payments cannot be guaranteed or processed quickly enough to cover these upfront costs, creating an unacceptable financial risk for our organization.